Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 118

Similar articles for PubMed (Select 24126686)

1.

Antipsychotic prescription filling in patients with schizophrenia or schizoaffective disorder.

Reutfors J, Brandt L, Stephansson O, Kieler H, Andersen M, Bodén R.

J Clin Psychopharmacol. 2013 Dec;33(6):759-65. doi: 10.1097/JCP.0b013e3182a1cd2e.

PMID:
24126686
2.

Early non-adherence to medication and other risk factors for rehospitalization in schizophrenia and schizoaffective disorder.

Bodén R, Brandt L, Kieler H, Andersen M, Reutfors J.

Schizophr Res. 2011 Dec;133(1-3):36-41. doi: 10.1016/j.schres.2011.08.024. Epub 2011 Oct 5.

PMID:
21982098
3.

Predictors of clozapine response in patients with treatment-refractory schizophrenia: results from a Danish Register Study.

Nielsen J, Nielsen RE, Correll CU.

J Clin Psychopharmacol. 2012 Oct;32(5):678-83. doi: 10.1097/JCP.0b013e318267b3cd.

PMID:
22926603
4.

Association between second-generation antipsychotic medication half-life and hospitalization in the community treatment of adult schizophrenia.

Broder MS, Bates JA, Jing Y, Hebden T, Forbes RA, Chang E.

J Med Econ. 2012;15(1):105-11. doi: 10.3111/13696998.2011.632042. Epub 2011 Oct 28.

PMID:
21991926
5.

Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.

Morrato EH, Dodd S, Oderda G, Haxby DG, Allen R, Valuck RJ.

Clin Ther. 2007 Jan;29(1):183-95.

PMID:
17379060
6.

Rates and predictors of antipsychotic non-adherence and hospitalization in Medicaid and commercially-insured patients with schizophrenia.

Lang K, Federico V, Muser E, Menzin J, Menzin J.

J Med Econ. 2013 Aug;16(8):997-1006. doi: 10.3111/13696998.2013.816310. Epub 2013 Jun 28.

PMID:
23777223
7.

Comparative effectiveness of second-generation antipsychotic medications in early-onset schizophrenia.

Olfson M, Gerhard T, Huang C, Lieberman JA, Bobo WV, Crystal S.

Schizophr Bull. 2012 Jun;38(4):845-53. doi: 10.1093/schbul/sbq172. Epub 2011 Feb 9.

8.

Evaluation of factors influencing medication compliance in inpatient treatment of psychotic disorders.

Janssen B, Gaebel W, Haerter M, Komaharadi F, Lindel B, Weinmann S.

Psychopharmacology (Berl). 2006 Aug;187(2):229-36. Epub 2006 May 19.

PMID:
16710714
9.
10.

Low treatment adherence with antipsychotics is associated with relapse in psychotic disorders within six months after discharge.

Laan W, van der Does Y, Sezgi B, Smeets HM, Stolker JJ, Wit NJ, Heerdink ER.

Pharmacopsychiatry. 2010 Aug;43(6):221-4. doi: 10.1055/s-0030-1254090. Epub 2010 May 25.

PMID:
20503150
11.

A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia.

Tiihonen J, Haukka J, Taylor M, Haddad PM, Patel MX, Korhonen P.

Am J Psychiatry. 2011 Jun;168(6):603-9. doi: 10.1176/appi.ajp.2011.10081224. Epub 2011 Mar 1. Erratum in: Am J Psychiatry. 2012 Feb;169(2):223.

PMID:
21362741
12.

Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders.

Keck PE Jr, Wilson DR, Strakowski SM, McElroy SL, Kizer DL, Balistreri TM, Holtman HM, DePriest M.

J Clin Psychiatry. 1995 Oct;56(10):466-70.

PMID:
7559373
13.

Prospective trial of customized adherence enhancement plus long-acting injectable antipsychotic medication in homeless or recently homeless individuals with schizophrenia or schizoaffective disorder.

Sajatovic M, Levin J, Ramirez LF, Hahn DY, Tatsuoka C, Bialko CS, Cassidy KA, Fuentes-Casiano E, Williams TD.

J Clin Psychiatry. 2013 Dec;74(12):1249-55. doi: 10.4088/JCP.12m08331.

14.

Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study.

Kroken RA, Johnsen E, Ruud T, Wentzel-Larsen T, Jørgensen HA.

BMC Psychiatry. 2009 May 16;9:24. doi: 10.1186/1471-244X-9-24.

15.

Time to discontinuation of first- and second-generation antipsychotic medications in the treatment of schizophrenia.

Kreyenbuhl J, Slade EP, Medoff DR, Brown CH, Ehrenreich B, Afful J, Dixon LB.

Schizophr Res. 2011 Sep;131(1-3):127-32. doi: 10.1016/j.schres.2011.04.028. Epub 2011 May 14.

PMID:
21576008
16.

Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities.

Citrome L, Jaffe A, Levine J.

Schizophr Res. 2010 Jun;119(1-3):153-9. doi: 10.1016/j.schres.2010.02.1066. Epub 2010 Mar 26.

PMID:
20347267
17.

Long-term effects of involuntary hospitalization on medication adherence, treatment engagement and perception of coercion.

Jaeger S, Pfiffner C, Weiser P, Längle G, Croissant D, Schepp W, Kilian R, Becker T, Eschweiler G, Steinert T.

Soc Psychiatry Psychiatr Epidemiol. 2013 Nov;48(11):1787-96. doi: 10.1007/s00127-013-0687-x. Epub 2013 Apr 19.

PMID:
23604621
18.

Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder.

Robinson D, Woerner MG, Alvir JM, Bilder R, Goldman R, Geisler S, Koreen A, Sheitman B, Chakos M, Mayerhoff D, Lieberman JA.

Arch Gen Psychiatry. 1999 Mar;56(3):241-7.

PMID:
10078501
19.

[Prescription practices of antipsychotic medication in early psychosis: a two-year follow-up survey of subjects admitted in two psychiatric hospitals of South-Western France].

Grolleau A, Cougnard A, Parrot M, Kalmi E, Desage A, Misdrahi D, Brun-Rousseau H, Verdoux H.

Encephale. 2007 May-Jun;33(3 Pt 1):326-31. French.

PMID:
17675930
20.

Guideline-concordant antipsychotic use and mortality in schizophrenia.

Cullen BA, McGinty EE, Zhang Y, Dosreis SC, Steinwachs DM, Guallar E, Daumit GL.

Schizophr Bull. 2013 Sep;39(5):1159-68. doi: 10.1093/schbul/sbs097. Epub 2012 Oct 30.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk